Welcome to Cochlear ProNews, your source for professional news that allows you to stay up to date on the latest research and hot topics in the hearing industry. Content includes surgical insights, clinical conversations, AudiologyOnline opportunities and peer-to-peer material. Also, don’t miss out on important information about our services and products such as the Nucleus® 8, Kanso® 2, Baha® 6 Max and Osia® Sound Processors. Subscribe now!

Featured posts

What’s new with the MSTB-3?

The Minimum Speech Test Battery, Version 3 (MSTB-3) is an updated and streamlined test battery designed for adult cochlear implantation. Developed by the Institute of Cochlear Implant Training (ICIT), this essential tool serves two main purposes: Pre-operative determination of candidacy: Clinicians use the MSTB-3 to assess whether a patient is a suitable candidate for cochlear implant (CI) surgery. Post-operative assessment of cochlear […]

Read More

Cochlear receives FDA clearance to lower the age for the Osia® System to 5 years old

Lone Tree, Colo. (April 19, 2024) – Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) clearance to lower the age of the Cochlear™  Osia System from 12 years-old to 5 years-old for children with conductive hearing loss, mixed hearing loss and single-sided sensorineural deafness (SSD). The Osia System is a new category […]

Read More

How Cochlear Implant Care is Changing

The number of cochlear implant (CI) candidates continues to grow due to expanding indications and an aging population. However, despite all the advancements in this field, the protocol and care model for CI patients hasn’t changed much since cochlear implants were first approved in the 1980s.(1,2) We have been inspired by the many industry leaders who have spoken about the need for […]

Read More

All posts